Columbia Science Review
  • Home
  • About
    • Executive Board
    • Editorial Board
  • Blog
  • Events
    • 2022-2023
    • 2021-2022
    • 2020-2021
    • 2019-2020
    • 2018-2019
    • 2017-2018
    • 2016-2017
  • Publications
  • COVID-19 Public Hub
    • Interviews >
      • Biology of COVID-19
      • Public Health
      • Technology & Data
    • Frontline Stories >
      • Healthcare Workers
      • Global Health
      • Volunteer Efforts
    • Resources & Links >
      • FAQ's
      • Resource Hubs
      • Student Opportunities
      • Podcasts & Graphics
      • Mental Health Resources
      • Twitter Feeds
      • BLM Resources
    • Columbia Events >
      • Campus Events
      • CUMC COVID-19 Symposium
      • CSR Events
    • Our Team
  • Contact

An Impulse of Hope for Individuals with Treatment-Resistant Depression

11/5/2013

0 Comments

 
Picture
By Erik Schiferle

As midterm season at Columbia is nearing an end, surely some students are suffering from the blues. Short periods of the blues are not out of the ordinary, especially for people in high stress environments. However, if an individual lacks a sense of well-being for extended periods of time or with an intensity great enough to create a loss of interest in daily activity, the individual may be suffering from a mood disorder.

According to the National Institute of Mental Health, approximately 11 percent of adolescents suffer from a depressive disorder by age 18 and approximately 9.5 percent of the U.S. population age 18 or older in a given year has a mood disorder. For many, psychological counseling and the use of psychiatric medication ease mood disorder symptoms. However, for some, standard treatments are not enough. Individuals that do not respond to standard treatments may have treatment-resistant depression or refractory depression. Unfortunately, there are no proven treatment options for individuals with treatment-resistant depression.

However, in a preliminary study of treatment-resistant depression, Helen S. Mayberg of Emory University and her colleagues observed that an area of the brain known as Brodmann area 25, or the subgenual cingulate, is extremely rich in serotonin transporters. The researchers also observed that Brodmann area 25 is metabolically overactive in individuals with treatment-resistant depression. They believed that the elevated levels of activity could be linked to the inability to treat the resistant form of depression. Using an experimental procedure known as Deep Brain Stimulation Surgery, the researchers performed a study in an attempt to reduce the elevated brain activity.

Deep Brain Stimulation Surgery involves implanting two metal electrodes into white matter tissue of the brain adjacent to Broadmann area 25, denoted “Cg25” in the photo. The electrodes are attached to an external power source that provides a high frequency impulse of electricity. The electrodes remain in the brain for an indefinite period of time to provide continuous stimulation. The six subjects upon whom the stimulation surgery was performed remained conscious during the procedure so that Mayberg and her colleagues could observe their mood changes. According to Mayberg in a publication released in 2005, “all patients reported acute effects including ‘sudden calmness or lightness,’ ‘disappearance of the void,’ a sense of heightened awareness, increased interest, ‘connectedness,’ and sudden brightening of the room.”

Mayberg and her colleagues concluded that continual stimulation of Broadmann area 25 resulted in remission of depression in four of the six patients. She reported that the electrical stimulation of the “subgenual cingulate white matter can effectively reverse symptoms in otherwise treatment-resistant depression.” However, A.L. Malizia of North Bristol NHS Trust and his colleagues reported earlier this year that Deep Brain Stimulation may not result in lasting benefits for patients with treatment-resistant depression. In their study of eight patients, only two patients achieved response/partial response, three patients had a temporary response, while the remaining three patients had no response. Malizia stated that a significantly larger group should be studied to confirm or refute his findings.

There is still much work to be done to develop treatments for people with treatment-resistant depression. However, in many cases, depression is treatable. Each year, depression claims the lives of many people that could have had successful treatment. Many of these deaths are preventable, but they continue to occur because of the stigmas associated with seeking help to battle the disease. Not only must great strides be made to develop alternative treatments for the disease, but also in the ability to convince people that there is nothing wrong with seeking help.
0 Comments



Leave a Reply.

    Categories

    All
    Artificial Intelligence
    Halloween 2022

    Archives

    November 2022
    October 2022
    June 2022
    January 2022
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    November 2019
    October 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    April 2018
    March 2018
    February 2018
    November 2017
    October 2017
    May 2017
    April 2017
    April 2016
    March 2016
    February 2016
    December 2015
    November 2015
    October 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    May 2014
    April 2014
    March 2014
    February 2014
    December 2013
    November 2013
    October 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    April 2011
    March 2011
    February 2011
    September 2010
    August 2010
    July 2010
    June 2010
    May 2010
    April 2010
    March 2010
    February 2010
    January 2010
    December 2009
    November 2009
    July 2009
    May 2009

Columbia Science Review
© COPYRIGHT 2022. ALL RIGHTS RESERVED.
Photos used under Creative Commons from driver Photographer, BrevisPhotography, digitalbob8, Rennett Stowe, Kristine Paulus
  • Home
  • About
    • Executive Board
    • Editorial Board
  • Blog
  • Events
    • 2022-2023
    • 2021-2022
    • 2020-2021
    • 2019-2020
    • 2018-2019
    • 2017-2018
    • 2016-2017
  • Publications
  • COVID-19 Public Hub
    • Interviews >
      • Biology of COVID-19
      • Public Health
      • Technology & Data
    • Frontline Stories >
      • Healthcare Workers
      • Global Health
      • Volunteer Efforts
    • Resources & Links >
      • FAQ's
      • Resource Hubs
      • Student Opportunities
      • Podcasts & Graphics
      • Mental Health Resources
      • Twitter Feeds
      • BLM Resources
    • Columbia Events >
      • Campus Events
      • CUMC COVID-19 Symposium
      • CSR Events
    • Our Team
  • Contact